Combined treatment of invasive giant prolactinomas

Pituitary

Volumn 8, Issue 1, 2005, Pages 61-65

  Yu, Chonjiang ^a   Wu, Zhebao ^a   Gong, Jian ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Bromocriptine; Pituitary adenoma; Prolactinoma; Transsphenoidal surgery

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUCOSE; PROLACTIN;

ABDUCENS NERVE PARALYSIS; ADULT; ANOSMIA; APHASIA; ARTICLE; CEREBROSPINAL FLUID FISTULA; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOTOMY; DEATH; DIABETES INSIPIDUS; ELECTROLYTE DISTURBANCE; EPIDURAL HEMATOMA; EPILEPSY; FEMALE; HEMIPLEGIA; HUMAN; HYPERGLYCEMIA; HYPOPHYSIS FUNCTION; KETOACIDOSIS; MALE; MENTAL DISEASE; NOSE MALFORMATION; OPHTHALMOPLEGIA; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROLACTINOMA; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; TRIGEMINAL NERVE DISEASE; VISION; VISUAL IMPAIRMENT; ADOLESCENT; BLOOD; CANCER INVASION; FOLLOW UP; HYPOPHYSIS; HYPOPHYSIS TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; BROMOCRIPTINE; COMBINED MODALITY THERAPY; CRANIOTOMY; DOPAMINE AGONISTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PITUITARY GLAND; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; TREATMENT OUTCOME;

EID: 33644856097     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-005-5087-0     Document Type: Article

References (18)

1. Shrivatava RK, Arginteanu MS, King WA, et al. Giant prolactinomas: clinical management and long-term follow up. J Neurosurg 2002; 97: 299-306.
2. Asano S, Ueki IK, Kirino T. Clinical features and medical treatment of male prolactinomas. Acta Neurochir(Wien) 2001; 143 (5): 465-475.
3. Molitch ME, Thorner O, Wilson C. Management of prolactinomas. J Clin Endocrinol Metab 1997; 82 (3): 996-1006.
4. Gokalp HZ, Deda H, Attar A, et al. The neurosurgical management of prolactinomas. J Neurosurg Sci 2000; 44: 128-132.
5. Loh KC, Schlossberg AH. Large macroprolactinoma treated with bromocriptine alone. Ann-Acad-Med-Singapore 1996; 25: 886-889.
6. Minniti G, Jaffrain-Rea ML, Santoro A, et al. Giant prolactinomas presenting as skull base tumors. Surg Neurol 2002; 57: 99-104.
7. Grebe SK, Delahunt JW, Feek CM. Treatment of extensively invasive (giant) prolactinomas with bromocriptine. N Z Med J 1992; 105 (931): 129-131.
8. Schofl-Siegert B, Brabant G, von zur Muhlen A, et al. Reversible blindness caused by an invasive prolactinoma. Dtsch med Wochenschr 2001; 126: 621-624.
9. Sieck JO, Niles NL, Jinkins JR, et al. Extrasellar prolactinomas: successful management of 24 patients using bromocriptine. Horm Res 1986; 23: 167-176.
10. Van't Verlaat JW, Croughs RJ, Hendricks MJ, et al. Results of primary treatment with bromocriptine of prolactinomas with extrasellar extension. Can J Neurol Sci 1990; 17: 71-73.
11. Clayton RN, Webb J, Heath DA, et al. Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: A case report. Clin Endocrinol (Oxf) 1985; 22: 573-581.
12. Moster ML, Savino PJ, Shatz NJ, et al. Visual function in prolactinoma patients treated with bromocriptine. Ophthalmology 1985; 92: 1332-1341.
13. Woodhouse NJ, Khoupueer F, Sieck JO. Prolactinomas and optic nerve compression: Disappearance suprasellar extension and visual recovery after two weeks bromocriptine treatment. Horm Res 1981; 14: 141-147.
14. Mbanya JC, Mendelow AD, Crawford PJ, et al. Rapid resolution of visual abnormalities with medical therapy alone in patients with large prolactinomas. Br J Neurosurg 1993; 7: 519-527.
15. Roux FX, Nataf F, Page P, Devaux B, Brami F. The role of surgery in the treatment of prolactinomas. Gynecol Obstet Fertil 2002; 30 (5): 367-373. Review. French.
16. Acquati S, Pizzocaro A, Tomei G, et al. A comparative evaluation of effectiveness of medical and surgical therapy in patients with macroprolactinoma. J Neurosurg Sci 2001; 45: 65-69.
17. Davis JR, Sheppard MC, Heath DA. Giant invasive prolactinoma; a case report and review of nine further cases. Q J Med 1990; 74: 227-238.
18. Saeki N, Nakamura M, Sunami K, et al. Surgical indication after bromocriptine therapy on giant prolactinomas: Effects and li mitations of the medical treatment. Endocr J 1998; 45 (4): 529-537.